Connect with us

AI Research

Cleantech Information | AZoCleantech.com – Page not found

Published

on


While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.

Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.

Please do not ask questions that use sensitive or confidential
information.

Read the full Terms & Conditions.



Source link

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

AI Research

Hong Kong start-up IntelliGen AI aims to challenge Google DeepMind in drug discovery

Published

on


IntelliGen AI, an artificial intelligence (AI) start-up founded in Hong Kong, is positioning itself as a competitor to Google DeepMind in the field of drug discovery, as the city increasingly seeks to bolster its AI capabilities.

In an interview with the Post, founder and president Ronald Sun expressed confidence that IntelliGen AI could soon compete globally with Isomorphic Labs, a spin-off of DeepMind, in leveraging AI for drug screening and design.

“For generative science, new breakthroughs and application opportunities are global in nature,” Sun said. “Within 12 to 18 months, we aim to land major, high-value clients on a par with Isomorphic.”

The term “generative science”, although not widely recognised yet, refers to the use of AI to model the natural world and facilitate scientific discovery.

Ronald Sun, founder and president of IntelliGen AI. Photo: Handout

The company’s ambitious plan follows the launch of its IntFold foundational model, which is designed to predict the three-dimensional structures of biomolecules, including proteins. The model’s accuracy levels were comparable to DeepMind’s AlphaFold 3, according to IntelliGen AI.



Source link

Continue Reading

AI Research

Hong Kong start-up IntelliGen AI aims to challenge Google DeepMind in drug discovery

Published

on


IntelliGen AI, an artificial intelligence (AI) start-up founded in Hong Kong, is positioning itself as a competitor to Google DeepMind in the field of drug discovery, as the city increasingly seeks to bolster its AI capabilities.

In an interview with the Post, founder and president Ronald Sun expressed confidence that IntelliGen AI could soon compete globally with Isomorphic Labs, a spin-off of DeepMind, in leveraging AI for drug screening and design.

“For generative science, new breakthroughs and application opportunities are global in nature,” Sun said. “Within 12 to 18 months, we aim to land major, high-value clients on a par with Isomorphic.”

The term “generative science”, although not widely recognised yet, refers to the use of AI to model the natural world and facilitate scientific discovery.

Ronald Sun, founder and president of IntelliGen AI. Photo: Handout

The company’s ambitious plan follows the launch of its IntFold foundational model, which is designed to predict the three-dimensional structures of biomolecules, including proteins. The model’s accuracy levels were comparable to DeepMind’s AlphaFold 3, according to IntelliGen AI.



Source link

Continue Reading

AI Research

July: Bristol AI partnership with France | News and features

Published

on


A new and unique supercomputing collaboration between the UK and France was announced at the UK-France Summit today (10 July).

As two of the most advanced countries in the development and use of AI for science, industry and public services, this partnership will significantly strengthen both countries’ national AI ecosystems and the wider European AI ecosystem.

The Bristol Centre for Supercomputing (BriCS) based at the University of Bristol and the Grand équipement national de calcul intensif (GENCI) will work on building and establishing a collaboration on supercomputing for the benefit of their respective communities and the broader European research ecosystem.

This joint initiative will foster bilateral scientific collaborations in the field of AI-specialisation across materials science, life sciences and medical, cybersecurity, AI security and safety, energy, and engineering, and more globally in AI for science.

The collaboration will ensure sharing of best practice on industrial involvement as well as establishing joint training and education tracks, exchange of students and researchers, hackathons, and the organisation of joint scientific seminars.

Both parties will collaborate in assessing new scientific and technical approaches including federated/distributed learning, agentic and frugal (cost efficient) AI, as well as jointly developed gathering and analysing information about advancements and trends in AI hardware and software. 

Professor Simon McIntosh-Smith, Director of the Bristol Centre for Supercomputing, said: “We are delighted to work alongside GENCI to deliver an innovative and productive European supercomputing ecosystem. Our AI supercomputer, Isambard-AI, is the 11th fastest and 4th greenest supercomputer in the world and having delivered on this project successfully and at pace, the BriCS team is perfectly positioned to co-lead this with the GENCI team.”

Professor Evelyn Welch, Vice-Chancellor and President of the University of Bristol, said: “The University of Bristol is proud to have forged this pioneering new European partnership that will enable unique collaboration with our French colleagues. We will continue to develop and grow the UK’s AI and supercomputing strategy alongside the Government, accelerating critical research and supporting industry innovations at home and internationally.”

A Letter of intention between BriCS and GENCI (PDF, 309kB) provides further information on the ambitions of the partnership.

Further information

About Isambard-AI

Isambard-AI is set to become the UK’s fastest and most powerful supercomputer, purpose-built for AI research following build completion in Summer 2025. Designed to provide open-source intelligence, it will transform research and drive AI-led breakthroughs in critical areas like automated drug discovery and climate research. 



Source link

Continue Reading

Trending